Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DENVER, June 22, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) announced today that it has completed its previously announced underwritten public offering...
-
DENVER, Colo., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) today announced the pricing of an underwritten offering of 40,000,000 shares of its...
-
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE...
-
Combination with Home Solutions Adds Experienced and Proven Leadership Team Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity Enhances Focus on Higher...
-
DENVER, June 13, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) today announced it has commenced an underwritten public offering of its common stock (the...
-
DENVER, May 05, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the first quarter 2016. For the first quarter, the Company...
-
DENVER, April 18, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 first quarter financial results on Thursday, May 5, 2016, after the...
-
BioScrip Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement
DENVER, April 01, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced that, in order to replace its expiring registration statement, it has...
-
Q4 Consolidated Adjusted EBITDA of $9.0 Million Reaffirms 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million DENVER, March 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc....
-
DENVER, Feb. 24, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 fourth quarter and year-end financial results on Wednesday, March 2,...